Tag Archives: FDA

FDA Approves Over-The-Counter Oxytrol for Women To Treat Overactive Bladder

January 25, 2013 The U.S. Food and Drug Administration today approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women ages 18 years and older. Oxytrol will remain available for men with overactive bladder by prescription … Continue reading

Posted in Breaking News | Tagged , , , , , , , | 9 Comments

FDA Approves Botox To Treat Overactive Bladder

January 18, 2013 The U.S. Food and Drug Administration today expanded the approved use of Botox (onabotulinumtoxinA) to treat adults with overactive bladder who cannot use or do not adequately respond to a class of medications known as anticholinergics. … Continue reading

Posted in Breaking News | Tagged , , , , , , | 10 Comments

Recent News Regarding Transvaginal Mesh

Johnson & Johnson ETHICON Women’s Health & Urology, a worldwide leader in surgical care, has announced its decision to cease sales and production of four GYNECARE products. The products that will be discontinued include: GYNECARE PROSIMA™ pelvic floor repair system … Continue reading

Posted in Breaking News | Tagged , , , , , , , , , , , | 17 Comments

FDA Approves Botox To Treat Specific Form of Urinary Incontinence

FDA NEWS RELEASE Read the original news release FDA Approves Botox To Treat Specific Form of Urinary Incontinence The U.S. Food and Drug Administration today approved Botox (onabotulinumtoxinA) injection to treat urinary incontinence in people with neurologic conditions such as … Continue reading

Posted in Breaking News | Tagged , , , , , , | 107 Comments

Surgical Placement of Mesh to Repair POP Poses Risks

FDA NEWS RELEASE FDA: Surgical placement of mesh to repair pelvic organ prolapse poses risks Agency says other options may expose women to less risk than transvaginal procedure The U.S. Food and Drug Administration today issued an updated safety communication … Continue reading

Posted in Breaking News | Tagged , , , , , , , , , , | 13 Comments